The 2018 Low-Dose Naltrexone (LDN) AIIC Conference is organized by Low Dose Naltrexone (LDN) Research Trust and will be held on Jul 07, 2018 at Wolfson Medical School Building, Glasgow, Scotland, United Kingdom.
Low-Dose Naltrexone (LDN) is quickly becoming the preferred treatment for a wide range of Auto-Immune and chronic diseases including MS, Crohn's, IBS, Colitis, Cancer, Autism, Rheumatoid Arthritis, ME/CFS, Fibromyalgia, and more.
Here is your opportunity to establish your company as a key player in the worldwide LDN community and take advantage of the growing momentum behind its efficacy.
The LDN AIIC 2018Conference is the only LDN focused event in the world. Here, the world’s leading experts and practitioners discuss the latest findings, experiences and case studies while suppliers and providers showcase their latest products and services.
Additional details will be posted as soon as they are available.